|
According to the Precision Medicine Initiative, precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals. Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health and healthcare in coming years. Information about Genetics Home Reference and precision medicine is available from the interactive Journal of Medical Research (i-JMR) article, "Information Needs in the Precision Medicine Era: How Genetics Home Reference Can Help." The Centers for Disease Control and Prevention covers precision medicine in its Genomics and Health Impact Blog. |
Announcements
NEWS ALERTS
Congratulations Dr. Mallory Williams on being selected as the recipient of the 2023 Shipley Award for your paper presentation
entitled, Early Cholecystectomy In Sickle Cell Patients With Gallstone Disease Is Associated With Better Outcomes, on December 5th at The Homestead. ... Read more
The Shipley award will be presented to Dr. Williams during the annual banquet of the 136th Annual Session of the Southern Surgical Association on Tuesday, December 10, 2024, at The Breakers in Palm Beach, FL.
The W. Montague Cobb Institute Mourns the Passing of Dr. Edith P. Mitchell, Trailblazer & Oncology Research Icon
The W. Montague Cobb Institute mourns the sudden and untimely loss of world-renowned cancer researcher and Vice-Chair of its Board of Directors and Chair of the Clinical Research Division. On Sunday, January 21, 2024, Dr. Edith P. Mitchell died doing what she enjoyed best - serving humanity and furthering the lives of cancer patients. Dr. Mitchell was a staunch advocate on cancer research and has been an outstanding Past President of the NMA and current Editor-In-Chief of the JNMA, where her contributions have been immense. She has provided leadership for the Cobb Institute including the establishment of the Jane Cooke Wright Cancer Symposium each year at the National Medical Association Convention and Scientific Assembly. "We share in the collective grief that is felt throughout the US and her contributions to the Cobb Institute will never be forgotten," stated Dr. Randall Morgan- President & CEO.
Dr. Mitchell was Board Certified in Internal Medicine and Medical Oncology and served as Clinical Professor of Medicine and Medical Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and Associate Director for Diversity Programs and Director of the Center to Eliminate Cancer Disparities for Sidney Kimmel Cancer Center at Jefferson.
Dr. Mitchell has spent her medical career helping individuals in underserved areas, and has demonstrated the importance of community service and outreach especially to underserved populations. Her research in breast, colorectal and pancreatic cancers and other Gl malignancies involved new drug evaluation and chemotherapy. development of new therapeutic regimens, chemoradiation strategies for combined modality therapy, patient selection criteria, and supportive care for patients with gastrointestinal cancer.
The 6-3 Supreme Court decision to overturn Grutter v. Bollinger both selectively dismantles Affirmative Action programs in higher education and conceptually threatens the continued existence of Historically Black Colleges and Universities, and therefore this ruling seeks to redefine our nation. Read Our Full Statement of Response from June 30, 2023. Read the Decision on SFFA v Harvard and the University of North Carolina.
Article released on the 2024 Medical Student Scholars for Health Equity in Myeloma program, a collaboration between the International Myeloma Foundation and the W. Montague Cobb/NMA Health Institute. Click here to apply -Learn more about the program here.
PAST EVENTS
Register to attend the 2023 National Medical Association (NMA) Annual Convention and Scientific Assembly in New Orleans where we host our 2023 Annual Program.
==========================================
COLLABORATOR HIGHLIGHTS
Please check out the Movement is Life Caucus Health Disparities Podcasts.
Partnering with J. Robert Gladden Orthopaedic Society
on the Stand United Campaign to end racial and ethnic
disparities in health and healthcare.
Twitter | Instagram | Facebook